Lifesciences isn’t one docket. Imaging probes, surgical robotics, implants, and drug-delivery systems face different examiner mixes and claim strategies. Ranking by allowance rate within the designated lifesciences CPCs isolates performance in the devices and instruments you actually prosecute. It levels the field across firm size and mix and centers the outcome clients care about: Did the work convert to granted rights in this industry? CPC granularity keeps comparisons apples-to-apples, so an implant specialist isn’t measured against a diagnostics-heavy docket, and vice versa.
The result: fair, comparable standings you can defend in a partner meeting or an RFP.
Life sciences spans diagnostics, surgical tools, implants, drug-delivery systems, and clinical instruments—often overlapping with biotech and health IT. To keep comparisons fair and apples-to-apples, we anchor this view to CPC subclasses that most directly capture patient-facing devices and instrumentation. That means we emphasize A61B, A61F, A61M, and include C12Q where the claimed subject matter centers on bioassay instrumentation used in care settings.
We're not including peripheral CPCs that touch life sciences indirectly. When CPCs span multiple industries, we classify by the primary CPC and the invention’s center of gravity.
Featured Firms
Life Science Industry
A rotating spotlight on top practices from our list
Didn't make the list?
You have the talent. You just need the industry's best data to guide your strategy. Book a session with an expert from Juristat to become a Top Patent Firm.
.png "Life science")
